Biotech
What Is a Biomarker? The Biological Signals Transforming Drug Development
What Is a Biomarker: Modern medicine runs on measurement. Before treating a disease, you need to detect it. Before knowing if a drug works, you
Coverage of early-stage science, platform technologies, R&D innovation, and emerging companies shaping the future of medicine. From discovery breakthroughs to financing rounds and pipeline progress, this section tracks the momentum driving the biotech ecosystem.
What Is a Biomarker: Modern medicine runs on measurement. Before treating a disease, you need to detect it. Before knowing if a drug works, you
Every week, billions of dollars shift in biotech based on a handful of pivotal moments: FDA decisions, clinical trial readouts, earnings calls, and conference presentations.
Biotech pay enters 2026 following 9% growth spike and 250+ layoff rounds creating bifurcated talent market; compensation shifts from equity to cash as funding stabilizes;
An In-Depth Analysis of the Most Promising Biotech Innovators Reshaping Healthcare The biotechnology landscape is experiencing a renaissance. As we approach 2026, a new generation
After more than half a year without a sizable biotech IPO, LB Pharmaceuticals just raised $285 million in an upsized Nasdaq offering. For an industry
After months of biotech companies avoiding public markets like the plague, LB Pharmaceuticals just broke the drought with a $285 million initial public offering that
August 2025 will be remembered as a watershed moment for the biotechnology industry, with over 20 companies announcing significant layoffs as the sector undergoes its
Taiwan-based biotech announces co-marketing agreement to push high-resolution subcellular mapping into new research frontiers Taiwan’s Syncell announced a strategic co-marketing agreement with Thermo Fisher Scientific
4,000-patient real-world study validates optimal ADC sequencing, driving strong investor confidence in precision oncology platform Caris Life Sciences shares surged following publication of breakthrough results
Strategic deal creates diversified specialty company with strong acute care presence and immediate revenue diversification CorMedix Inc. announced the completion of its $300 million acquisition